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Abstract Elongation factor Tu (EF-Tu) is the most abundant protein in prokaryotic ells. Its general function in protein biosynthesis i well 
established. It is a member of the large family of G-proteins, all of which bind guanosine phosphates (GDP or GTP) as cofactors. In its active GTP 
bound state EF-Tu binds aminoacylated tRNA (aa-tRNA) forming the ternary complex EF-Tu : GTP: aa-tRNA. The ternary complex interacts with 
the rlbosome where the anticodon on tRNA recognises a codon on mRNA, GTPase activity is induced and inactive EF-Tu: GDP is released. Here 
we report he successful crystallization of a ternary complex of Thermus aquaticus EF-Tu : GDPNP and yeast Phe-tRNAPhe aft r its purification by 
HPLC. 
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1. Introduction 
Protein biosynthesis is performed on the ribosome, which is 
a large complex of ribosomal RNA (rRNA) and proteins [1,2]. 
Ribosomes are in all species divided into two subunits. In bac- 
teria these are the 50s and 30s particles of the 70s ribosome. 
The biosynthesis of proteins on the ribosome is divided into 
three phases: initiation, elongation, and termination. During 
initiation messenger RNA (mRNA) is bound to the 30s particle 
and the start codon on mRNA is recognised by initiator trans- 
fer RNA. Initiation factors thereafter catalyse the assembly of 
the 70s ribosome in the initiation complex. Termination is 
catalysed by one of several termination or release factors when 
ribosomes expose a stop codon. 
Elongation is catalysed by three elongation factors [3,4]. 
Elongation factor Tu (EF-Tu) forms an active ternary complex 
with aminoacyl-tRNA (aa-tRNA) and guanosine triphosphate 
(GTP). This ternary complex assists the aa-tRNA in recog- 
nising an exposed codon on the ribosome and positions the aa- 
tRNA on the ribosomal A-site. Ribosomes induce hydrolysis 
of GTP to guanosine diphosphate (GDP), and the binary com- 
plex EF-Tu : GDP is ejected from the ribosome [2]. The nucleo- 
tide exchange factor Ts (EF-Ts) binds EF-Tu: GDP and cata- 
lyses the rapid exchange of GDP for GTP. A peptidyltrans- 
ferase centre on the ribosome catalyses the transfer of the 
growing peptide on a peptidyl-tRNA in the P-site of the ribo- 
some to the aminoacid on tRNA in the A-site, leaving a deacyl- 
ated tRNA in the P-site. A translocation reaction is catalysed 
by elongation factor G (EF-G) whereby deacylated-tRNA is 
translocated to the E-site, peptidyl-tRNA is translocated to the 
P-site and in the A-site the next codon is exposed for recogni- 
tion by a new ternary complex aa-tRNA: EF-Tu:GTP [3,4]. 
The E-site has been shown by Nierhaus and coworkers to have 
a negative allosteric effect on binding of the ternary complex 
to the A-site [l]. The ribosome is thus thought to be in one of 
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two states: the pre-translocation state with aa-tRNA in the 
A-site and peptidyl-tRNA in the P-site or the post-transloca- 
tion state with peptidyl-tRNA in the P-site and deacylated- 
tRNA in the E-site. Furthermore, it has been shown that 
tRNAs can be found in mixed states according to the state of 
the ribosome during elongation, i.e. after peptidyl transfer 
tRNA is at P-site on 50s but in A-site on 30s [2]. 
It has been proposed that two EF-Tu molecules participate 
in the recognition of aa-tRNA thus forming a pentameric om- 
plex, aa-tRNA: (EF-Tu : GTP), [5,6] This model implies that 
two GTP molecules are hydrolysed when the tRNA is delivered 
to the ribosome, a result which is in agreement with the findings 
of Weijland and Parmeggiani [7]. However, they do point out 
that their results can also be explained by a sequential action 
of two ternary complexes. EF-Tu and EF-G are members of 
the GTP-binding protein family which includes ras-p21, 
transducin and the heterotrimeric G-proteins [8]. They all share 
common sequence motifs which are involved in binding of 
guanine nucleotides [9]. Crystal structures are known of 
EF-Tu: GDP from E. coli [lo], of EF-Tu: GTP from 
7: thermophilus [ll] and from 7: aquaticus [12]. Crystal struc- 
tures have been determined of nucleotide-free EF-G [13] and 
EF- G: GDP [14] from r thermophilus. Crystal structures have 
also been determined of p2 1: GDP [ 151, ~21: GTP [ 161, bovine 
transducin a: GDP [17] and bovine transducin a: GTP [ 181. 
These proteins generally have two distinct states. An active 
GTP-bound form and an inactive form where GDP is bound. 
The active form will interact with its target effector whereafter 
GTP is hydrolysed to GDP and inorganic phosphate. The G- 
proteins constitute a superfamily of proteins with a conserved, 
common structural design [8]. Thus results obtained for one 
protein can to a certain degree be applied to other proteins in 
the superfamily. 
Elongation factor Tu from Thermus aquaticus is a mono- 
meric protein of 405 amino acid residues and a molecular 
weight of 44.6 kDa. In 7: aquaticus [19] two genes encode 
EF-Tu: tufA and tufB. The exsistence of two genes coding for 
EF-Tu is likely to be part of a complicated bioregulatory mech- 
anism [20]. Yeast tRNAPhe has 76 nucleotides and a molecular 
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weight of 25 kDa. Here we report the successful crystallization 
of the ternary complex of yeast Phe-tRNAPhe with EF- 
Tu:GDPNP from Thermus aquaticus. The eventual 
determination of the crystal structure of the ternary complex 
will undoubtedly give new important views on one part of the 
central elongation phase in protein biosynthesis and on 
biomolecular recognition between proteins and nucleic acids. 
2. Materials and methods 
EF-Tu was purified from a cellpaste of Thermus aquaticus YT-1 
(DSM, Germany) and EF-Tu: GDPNP prepared essentially as de- 
scribed earlier [12] except hat a soluble alkaline phosphatase (Bohrin- 
ger, Germany) was used. Phe-tRNAPhe was formed by incubation of 
tRNAPh” from brewers yeast (Biihringer, Germany) with yeast Phe-RS, 
[14C]Phe and ATP [21]. Gel filtration of the ternary complex (TC) was 
carried out on a TosoHaas G-3OOOSW HPLC column (in 50 mM 
Tris-HCl, 100 mM KCl, 40 mM NH&l, 10 mM MgCl,, 0.5 mM NaN,, 
0.5 mM DTT, 10 PM GDPNP, pH 7.0) at room temperature. The 
TC-pool was concentrated after addition of 30% ammonium sulphate 
(AS) in Centricon- tubes to a concentration exceeding 1 mg/ml and 
precipitated in 65% AS. Reverse fractional extraction was performed 
in 100 ~1 volumes of AS containing buffer solutions (60-40% AS, 30 
mM Tris-HCl, 5 mM MES, 7 mM MgCl,, 0.5 mM DTT, 0.5 mM NaN, 
and 0.2 mM GDPNP, pH 7.0) with a 2.5% AS decrease per step. The 
concentration of EF-Tu: GDPNP was measured by calorimetric meth- 
ods with a BSA standard and by counting of the EF-Tu bound 
[‘HIGDPNP. The concentration of Phe-tRNAPhe was measured by 
counting of [‘4C]Phe-tRNA”“. 
3. Results and discussion 
An earlier attempt at the crystallization of the ternary com- 
plex was reported by Kaziro et al. [22]. In unpublished experi- 
ments, using powder diffraction on crystals produced under 
similar conditions to the ones reported, it was shown that these 
crystals most likely contained EF-Tu:GDP (T.F.M. la Cour 
and J. Nyborg, 1974, unpublished). 
Many laboratories have since then tried to crystallize the 
ternary complex. The attempts have been hampered by the fact 
that the complex contains two sources of instability. One is the 
ester bond between the amino acid and tRNA which is easily 
hydrolysed in aqueous solutions. This, and the fact that 
EF-Tu : GTP protects aa-tRNA against RNAse hydrolysis, 
have been used to study stabilities of ternary complexes [23]. 
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Fig. 1. Purification of ternary complex by HPLC gel filtration. (a) Peak 
of EF-Tu : GDPNP: Phe-tRNA”“. (b) Peak of uncomplexed tRNAPh’. 
(c) Peak of uncomplexed EF-Tu : GDPNP. 
Fig. 2. Single monoclinic crystal of ternary complex. Crystal dimen- 
sions are 0.7, 0.5 and 0.3 mm. 
The other instability is the intrinsic hydrolysis of GTP and the 
fact that the affinity of EF-Tu for GDP is two orders of mag- 
nitude higher than its affinity for GTP. These problems have 
spurred many biochemical experiments with the aim of identify- 
ing regions or residues on tRNA or EF-Tu that are involved 
in binding each other. Several recent reviews summarize these 
experiments [24-261. 
The crystal structures of the components of the ternary com- 
plex are known. The first well diffracting crystals of yeast 
tRNAPh” were reported in 1968 [27]. Crystallization of EF- 
Tu:GDP was reported in 1973 [28]. The structure of 
yeast tRNAPh” has been known since 1974 [29-301. The stable 
but inactive EF-Tu:GDP from E. coli has been the subject of 
several crystallographic investigations over more than 15 years 
(see [lo] and references therein). Recently the structures of the 
active EF-Tu: GDPNP from 7: thermophilus [l l] and from 
T aquaticus [12] have been determined. Attempts at getting 
information on the overall structure and possible conforma- 
tional changes of aa-tRNA and/or EF-Tu during ternary com- 
plex formation include small angle neutron diffraction experi- 
ments. The results are confusing as one report indicates a rather 
elongated complex [3 l] while the other suggests a compact one 
[32]. These structural results together with the wealth of bio- 
chemical data have resulted in different attempts at predicting 
the structure of the ternary complex. Owing to the large confor- 
mational change of EF-Tu in the transition from EF-Tu: GDP 
to EF-Tu:GTP earlier predictions have been erroneous [24- 
261. More recent predictions are in this respect more reliable 
v51. 
It was found rather early that the ternary complex with 
Val-tRNAVa’ shows increased stability in high concentrations 
of ammonium sulphate (AS) and ammonium citrate [33]. These 
experiments were repeated, showing that this was generally true 
for other ternary complexes [34]. In the same paper it was 
reported that ternary complexes were also more stable in poly- 
ethylene glycol (PEG). Purification of milligram quantities of 
ternary complexes, free of deacylated tRNA and inactive EF- 
Tu, was shown to be possible using HPLC gel filtration [21]. 
The same report showed that ternary complexes could be 
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isolated by a fractional extraction in the presence of AS or PEG 
and that concentrated samples of ternary complex exhibits in- 
creased stability. 
In our laboratory the ternary complex of EFTu : GDPNP: 
Phe-tRNAPhe was formed by incubation of Thermus aquaticus 
EF-Tu: GDPNP with a preparation of yeast Phe-tRNAPZ”. The 
complex was separated from other components of the reaction 
mixture by HPLC silica gel filtration in a high ionic strength 
buffer (Fig. 1). The high ionic strength increases the elution 
volume of free EF-Tu due to unspecific binding. The ternary 
complex in the precipitated pool was further purified by reverse 
fractional extraction. Excess tRNA and EF-Tu appeared at 
60% and 45% AS, respectively. The ternary complex was ex- 
tracted in fractions from 55% to 47.5% AS. Fractions of ternary 
complex, at a molar ratio of EF-Tu: GDPNP over Phe- 
tRNAPh” equal to 1 were used for crystallization by the vapor 
diffusion method using hanging or sitting drops. The final yield 
of pure EF-Tu: GDPNP:Phe-tRNAPh” was about 30% of the 
starting materials (Phe-tRNAPh”). 
Single crystals of rhombohedral shape appeared within three 
to five days of equilibration at 4°C (Fig. 2). Crystallization 
conditions were: 20 mM Tris-HCl (pH 7.6), 3 mM MES (pH 
2.7), 35% AS, 7 mM MgCl,, 0.5 mM NaN,, 0.5 mM DTT and 
0.4 mM GDPNP with a final concentration of 15 mg TC per 
ml in the drop and 4749% AS, pH 6.7-7.0 in the reservoir. It 
was noted that a concentration of GDPNP in a 2- to 4-fold 
excess over the concentration of EF-Tu was critical for the 
growth of single crystals. Crystals of size 0.7x0.5x 0.3 mm3 
were obtained within 14 days . The crystals were stable in a 
buffer with 65% AS and could be kept for at least two months. 
Carefully washed and redissolved crystals showed the unique 
presence of EF-Tu and Phe-tRNAPh in the initial molar ratio 
on a silverstained SDS-PAGE (Fig. 3). 
Crystals forming hexagonal plates were obtained of a ternary 
complex of E. coli EF-Tu: GDPNP and yeast Phe-tRNAPh’. 
The main difference was in the use of lower concentrations of 
AS in precipitation and in fractional extraction. However, these 
crystals were less stable and further work on them was not 
Fig. 3. Silver stained SDS-PAGE in 18% polyacrylamide of redissolved 
crystals of the ternary complex. Lane a, molecular weight markers (90, 
65, 43, 30, 21 kDa); lane b, EF-Tu:GDPNP preparation; lane c, 
tRNA”” from brewers yeast (Biihringer); lane d, a 1: 1 molar mixture 
of EF-Tu and tRNAPhe; Lane e, washed and redissolved crystal of TC; 
Lane f, mother liquor of TC crystals; lane g, Purified TC (1: 1) in 
crystallization buffer; lane h, molecular weight markers. 
Fig. 4. Oscillation photograph of crystals of the ternary complex ob- 
tained at SRS station 9.6. The wavelength was 0.88 A. The oscillation 
range was 1.0”. The maximum resolution is 2.8 A. 
carried out. Attempts to crystallize a pentameric complex re- 
sulted in crystals of EF-Tu: GDPNP. 
A sucrose concentration of 20% was found suitable for data 
collection at cryogenic temperatures [35]. Diffraction data were 
collected to 2.8 A resolution at SRS, Daresbury, station 9.6 
(Fig. 4). The crystal system is monoclinic, spacegroup C2, with 
cell dimensions a = 208.28 A, b = 122.30 A, c = 151.8111, 
jI = 126.70”. Calculations give three to six ternary complexes 
per asymmetric unit assuming a normal range of solvent con- 
tent. 
The crystallization of the ternary complex described above 
is the first crucial step in the successful elucidation of its spatial 
structure by X-ray crystallographic analysis. 
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